MedTrace Logo

Reducing Antibiotic Prescriptions for Urinary Tract Infection in Long-Term Care Facilities

NCT03715062 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1491

Last updated 2019-06-04

No results posted yet for this study

Summary

This cluster randomized controlled study evaluates the effect of a tailored observation, reflection and communication tool on used by long-term care facility staff on antibiotic prescription for urinary tract infection in long-term care facility residents.

Conditions

Interventions

OTHER

Dialogue tool

The intervention has two parts: an educational session and a dialogue tool. The educational session consists of 75 minutes of education in diagnosing urinary tract infection. The dialogue tool consists of 1) a checking box for the most important symptoms and observations for urinary tract infection 2) an algorithm to evaluate if urinary tract infection is likely based on the present symptoms and observations 3) a list of reflection points to evaluate with a collegue 4) a specialized ISBAR (communication tool) if long-term care facility staff finds it appropriate to contact the General Practicioner

Sponsors & Collaborators

  • Ministry of the Interior and Health, Denmark

    collaborator OTHER_GOV

  • Velux Fonden

    collaborator OTHER

  • Herlev Hospital

    collaborator OTHER

  • Research Unit Of General Practice, Copenhagen

    lead OTHER

Principal Investigators

  • Lars Bjerrum, MD, PHD · Professor

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2019-03-31
Completion
2019-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03715062 on ClinicalTrials.gov